Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 57 | 2023 | 203 | 11.210 |
Why?
|
Interleukin-15 | 22 | 2020 | 72 | 4.980 |
Why?
|
Intestinal Mucosa | 41 | 2023 | 797 | 3.510 |
Why?
|
Glutens | 22 | 2023 | 76 | 2.880 |
Why?
|
Autoimmune Diseases | 10 | 2024 | 241 | 2.790 |
Why?
|
T-Lymphocytes, Cytotoxic | 11 | 2022 | 315 | 2.490 |
Why?
|
Immunity, Innate | 10 | 2023 | 409 | 2.050 |
Why?
|
Killer Cells, Natural | 12 | 2022 | 267 | 1.830 |
Why?
|
Receptors, Antigen, T-Cell | 11 | 2021 | 372 | 1.610 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 7 | 2015 | 29 | 1.580 |
Why?
|
CD4-Positive T-Lymphocytes | 11 | 2023 | 425 | 1.560 |
Why?
|
Self Tolerance | 3 | 2024 | 24 | 1.550 |
Why?
|
T-Lymphocytes | 20 | 2023 | 1195 | 1.460 |
Why?
|
Intestine, Small | 12 | 2023 | 303 | 1.450 |
Why?
|
Autoimmunity | 8 | 2024 | 160 | 1.430 |
Why?
|
HLA-DQ Antigens | 8 | 2020 | 52 | 1.380 |
Why?
|
Interferon-gamma | 8 | 2023 | 444 | 1.320 |
Why?
|
Autoantigens | 2 | 2024 | 127 | 1.320 |
Why?
|
Epithelial Cells | 6 | 2023 | 669 | 1.310 |
Why?
|
Gastrointestinal Microbiome | 13 | 2023 | 455 | 1.230 |
Why?
|
Cholangitis, Sclerosing | 3 | 2023 | 52 | 1.180 |
Why?
|
Receptors, Immunologic | 8 | 2017 | 135 | 1.170 |
Why?
|
Inflammation | 10 | 2023 | 920 | 1.170 |
Why?
|
Colon | 8 | 2023 | 496 | 1.140 |
Why?
|
Th1 Cells | 6 | 2018 | 164 | 1.140 |
Why?
|
T-Lymphocyte Subsets | 5 | 2021 | 272 | 1.140 |
Why?
|
Antigen Presentation | 4 | 2024 | 209 | 1.130 |
Why?
|
Gliadin | 8 | 2022 | 17 | 1.070 |
Why?
|
Antigens | 8 | 2023 | 228 | 1.060 |
Why?
|
Microbiota | 6 | 2023 | 381 | 1.030 |
Why?
|
Immune Tolerance | 8 | 2023 | 337 | 1.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 6 | 2019 | 102 | 1.010 |
Why?
|
Animals | 62 | 2024 | 26582 | 1.000 |
Why?
|
Signal Transduction | 16 | 2020 | 3241 | 0.970 |
Why?
|
Dendritic Cells | 7 | 2023 | 425 | 0.960 |
Why?
|
Humans | 106 | 2024 | 86643 | 0.950 |
Why?
|
Desensitization, Immunologic | 1 | 2024 | 36 | 0.940 |
Why?
|
Colitis | 5 | 2023 | 239 | 0.900 |
Why?
|
Transglutaminases | 6 | 2021 | 39 | 0.890 |
Why?
|
Intraepithelial Lymphocytes | 5 | 2020 | 16 | 0.850 |
Why?
|
Adaptive Immunity | 4 | 2021 | 164 | 0.840 |
Why?
|
Mice | 42 | 2024 | 11352 | 0.830 |
Why?
|
Phospholipases A2, Cytosolic | 2 | 2013 | 4 | 0.830 |
Why?
|
Lymphocytes | 4 | 2018 | 464 | 0.820 |
Why?
|
Inflammatory Bowel Diseases | 6 | 2023 | 549 | 0.770 |
Why?
|
Lymphocyte Activation | 8 | 2018 | 728 | 0.760 |
Why?
|
Histocompatibility Antigens Class I | 9 | 2018 | 203 | 0.760 |
Why?
|
Epitopes, T-Lymphocyte | 5 | 2022 | 89 | 0.720 |
Why?
|
Mice, Inbred C57BL | 21 | 2020 | 3092 | 0.690 |
Why?
|
GTP-Binding Proteins | 4 | 2021 | 146 | 0.680 |
Why?
|
Diet | 4 | 2023 | 443 | 0.680 |
Why?
|
Caliciviridae Infections | 1 | 2018 | 11 | 0.680 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 4 | 2014 | 7 | 0.670 |
Why?
|
Norovirus | 1 | 2018 | 13 | 0.670 |
Why?
|
HLA Antigens | 6 | 2019 | 232 | 0.670 |
Why?
|
Colorectal Neoplasms | 2 | 2023 | 938 | 0.670 |
Why?
|
Intestines | 5 | 2017 | 411 | 0.660 |
Why?
|
Ovalbumin | 1 | 2018 | 109 | 0.660 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 4 | 2014 | 7 | 0.650 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2019 | 559 | 0.640 |
Why?
|
Metagenome | 5 | 2023 | 102 | 0.580 |
Why?
|
Cell Differentiation | 7 | 2018 | 1458 | 0.560 |
Why?
|
Vaccines | 2 | 2017 | 80 | 0.550 |
Why?
|
Salmonella Infections | 1 | 2015 | 18 | 0.550 |
Why?
|
Salmonella typhimurium | 1 | 2015 | 32 | 0.540 |
Why?
|
Leukotrienes | 1 | 2015 | 20 | 0.540 |
Why?
|
Gene Expression Regulation | 7 | 2020 | 1920 | 0.540 |
Why?
|
Models, Immunological | 7 | 2018 | 80 | 0.540 |
Why?
|
Plague | 4 | 2008 | 27 | 0.540 |
Why?
|
Food Hypersensitivity | 2 | 2019 | 63 | 0.530 |
Why?
|
Immunity, Cellular | 1 | 2015 | 177 | 0.520 |
Why?
|
Capillary Permeability | 1 | 2015 | 130 | 0.520 |
Why?
|
Cysteine | 1 | 2015 | 135 | 0.510 |
Why?
|
Yersinia pestis | 4 | 2008 | 24 | 0.490 |
Why?
|
Cell Proliferation | 6 | 2019 | 1578 | 0.490 |
Why?
|
Cytokines | 6 | 2020 | 776 | 0.470 |
Why?
|
Tumor Microenvironment | 3 | 2015 | 418 | 0.470 |
Why?
|
Arthritis, Psoriatic | 1 | 2013 | 32 | 0.460 |
Why?
|
Cytoplasm | 1 | 2014 | 281 | 0.460 |
Why?
|
Antigens, Bacterial | 3 | 2008 | 134 | 0.450 |
Why?
|
Protein Processing, Post-Translational | 3 | 2023 | 371 | 0.450 |
Why?
|
Toll-Like Receptor 1 | 1 | 2012 | 6 | 0.440 |
Why?
|
Yersinia Infections | 1 | 2012 | 5 | 0.440 |
Why?
|
Th17 Cells | 2 | 2012 | 80 | 0.440 |
Why?
|
Yersinia enterocolitica | 1 | 2012 | 18 | 0.430 |
Why?
|
Receptors, Interleukin-12 | 2 | 2011 | 9 | 0.430 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 302 | 0.430 |
Why?
|
Cells, Cultured | 12 | 2018 | 2818 | 0.430 |
Why?
|
HEK293 Cells | 4 | 2019 | 615 | 0.430 |
Why?
|
Lectins, C-Type | 3 | 2014 | 85 | 0.430 |
Why?
|
Antigens, CD | 5 | 2017 | 458 | 0.420 |
Why?
|
Administration, Oral | 5 | 2018 | 684 | 0.420 |
Why?
|
Receptors, Natural Killer Cell | 6 | 2017 | 20 | 0.420 |
Why?
|
NFATC Transcription Factors | 1 | 2011 | 29 | 0.410 |
Why?
|
Disease Models, Animal | 9 | 2022 | 2232 | 0.410 |
Why?
|
Mice, Transgenic | 11 | 2022 | 1540 | 0.410 |
Why?
|
Interleukin-12 | 2 | 2011 | 108 | 0.400 |
Why?
|
RNA, Untranslated | 1 | 2011 | 63 | 0.400 |
Why?
|
Interleukin-10 | 6 | 2019 | 149 | 0.390 |
Why?
|
Immunity, Mucosal | 5 | 2023 | 69 | 0.380 |
Why?
|
Tretinoin | 1 | 2011 | 126 | 0.370 |
Why?
|
Pore Forming Cytotoxic Proteins | 3 | 2008 | 54 | 0.370 |
Why?
|
Adjuvants, Immunologic | 1 | 2011 | 167 | 0.360 |
Why?
|
Immunity | 3 | 2020 | 136 | 0.360 |
Why?
|
Cell Nucleus | 1 | 2011 | 579 | 0.350 |
Why?
|
Toll-Like Receptor 2 | 4 | 2018 | 33 | 0.340 |
Why?
|
Toll-Like Receptor 6 | 1 | 2008 | 5 | 0.340 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 3 | 2018 | 100 | 0.330 |
Why?
|
Membrane Proteins | 2 | 2018 | 1196 | 0.330 |
Why?
|
Immunotherapy | 2 | 2015 | 629 | 0.330 |
Why?
|
Ligands | 4 | 2022 | 433 | 0.330 |
Why?
|
Crohn Disease | 4 | 2023 | 730 | 0.330 |
Why?
|
Reoviridae Infections | 2 | 2018 | 7 | 0.320 |
Why?
|
Virulence Factors | 1 | 2008 | 108 | 0.320 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 1197 | 0.310 |
Why?
|
Fecal Microbiota Transplantation | 4 | 2023 | 62 | 0.300 |
Why?
|
Immunologic Factors | 1 | 2008 | 170 | 0.300 |
Why?
|
Bacteria | 4 | 2023 | 447 | 0.290 |
Why?
|
Cell Line | 9 | 2019 | 2468 | 0.290 |
Why?
|
Butyrates | 2 | 2016 | 42 | 0.290 |
Why?
|
Autoantibodies | 4 | 2015 | 267 | 0.280 |
Why?
|
Flow Cytometry | 7 | 2015 | 679 | 0.280 |
Why?
|
Immunoglobulin A | 2 | 2017 | 80 | 0.280 |
Why?
|
Diet, Gluten-Free | 4 | 2019 | 52 | 0.280 |
Why?
|
Up-Regulation | 4 | 2019 | 712 | 0.280 |
Why?
|
Phosphorylation | 4 | 2011 | 1106 | 0.280 |
Why?
|
Homeostasis | 4 | 2015 | 409 | 0.260 |
Why?
|
Bacterial Infections | 3 | 2018 | 182 | 0.260 |
Why?
|
Mice, Knockout | 5 | 2015 | 1924 | 0.260 |
Why?
|
Case-Control Studies | 8 | 2019 | 1805 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 8 | 2018 | 2271 | 0.260 |
Why?
|
Interleukin-15 Receptor alpha Subunit | 2 | 2015 | 6 | 0.260 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 819 | 0.250 |
Why?
|
Colitis, Ulcerative | 4 | 2017 | 711 | 0.250 |
Why?
|
Intestinal Neoplasms | 2 | 2002 | 56 | 0.250 |
Why?
|
Dioxygenases | 2 | 2022 | 74 | 0.250 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2011 | 295 | 0.250 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 1208 | 0.240 |
Why?
|
Interleukin-1alpha | 1 | 2023 | 4 | 0.240 |
Why?
|
Macrophages | 2 | 2023 | 554 | 0.240 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2015 | 567 | 0.240 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 22 | 0.240 |
Why?
|
Inflammasomes | 1 | 2023 | 23 | 0.240 |
Why?
|
Interleukin-1beta | 1 | 2023 | 78 | 0.230 |
Why?
|
Sepsis | 2 | 2020 | 306 | 0.230 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 112 | 0.230 |
Why?
|
Complement Factor B | 1 | 2023 | 9 | 0.230 |
Why?
|
Antigen-Presenting Cells | 1 | 2024 | 139 | 0.230 |
Why?
|
Hematopoiesis | 2 | 2023 | 163 | 0.230 |
Why?
|
Antigens, CD1d | 2 | 2013 | 29 | 0.230 |
Why?
|
GATA4 Transcription Factor | 1 | 2023 | 17 | 0.230 |
Why?
|
Female | 29 | 2020 | 44532 | 0.230 |
Why?
|
Protein Binding | 3 | 2017 | 1456 | 0.230 |
Why?
|
Enterobacteriaceae Infections | 1 | 2023 | 23 | 0.220 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2002 | 8 | 0.220 |
Why?
|
Adenosine Triphosphatases | 1 | 2023 | 153 | 0.220 |
Why?
|
Goblet Cells | 1 | 2022 | 19 | 0.220 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 314 | 0.220 |
Why?
|
Hepatitis, Autoimmune | 1 | 2022 | 19 | 0.210 |
Why?
|
Lymphocyte Count | 1 | 2022 | 94 | 0.210 |
Why?
|
Molecular Sequence Data | 6 | 2014 | 3030 | 0.210 |
Why?
|
Neoplasms | 3 | 2013 | 2898 | 0.210 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2023 | 456 | 0.210 |
Why?
|
RNA, Ribosomal, 16S | 6 | 2023 | 241 | 0.210 |
Why?
|
Male | 27 | 2020 | 40965 | 0.210 |
Why?
|
Interferon Regulatory Factor-1 | 2 | 2018 | 19 | 0.210 |
Why?
|
Orthoreovirus, Mammalian | 2 | 2018 | 2 | 0.210 |
Why?
|
Germ-Free Life | 6 | 2019 | 69 | 0.210 |
Why?
|
Urine | 1 | 2022 | 90 | 0.200 |
Why?
|
CD28 Antigens | 1 | 2001 | 88 | 0.200 |
Why?
|
Bone Marrow | 1 | 2023 | 435 | 0.200 |
Why?
|
Interleukin-23 | 2 | 2012 | 54 | 0.200 |
Why?
|
Amino Acid Sequence | 5 | 2022 | 2062 | 0.190 |
Why?
|
Antigens, CD1 | 2 | 2007 | 35 | 0.190 |
Why?
|
Cell Communication | 2 | 2015 | 194 | 0.190 |
Why?
|
Proteome | 1 | 2022 | 124 | 0.190 |
Why?
|
Adult | 18 | 2019 | 25648 | 0.190 |
Why?
|
Chronic Disease | 2 | 2019 | 971 | 0.190 |
Why?
|
Dysbiosis | 2 | 2022 | 70 | 0.190 |
Why?
|
Alarmins | 1 | 2020 | 4 | 0.190 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2019 | 12 | 0.180 |
Why?
|
Proteolysis | 2 | 2019 | 100 | 0.180 |
Why?
|
Percutaneous Coronary Intervention | 1 | 2020 | 58 | 0.180 |
Why?
|
Receptor, PAR-2 | 1 | 2019 | 3 | 0.180 |
Why?
|
C-Reactive Protein | 1 | 2020 | 190 | 0.170 |
Why?
|
Benzodiazepines | 1 | 2019 | 65 | 0.170 |
Why?
|
Peptide Fragments | 2 | 2018 | 460 | 0.170 |
Why?
|
Butyrophilins | 1 | 2019 | 22 | 0.170 |
Why?
|
Epitopes | 2 | 2017 | 255 | 0.170 |
Why?
|
Dietary Proteins | 1 | 2019 | 30 | 0.170 |
Why?
|
Metalloendopeptidases | 1 | 2019 | 45 | 0.170 |
Why?
|
Capsid Proteins | 1 | 2018 | 32 | 0.170 |
Why?
|
Interleukins | 1 | 2019 | 134 | 0.170 |
Why?
|
Heat-Shock Proteins | 4 | 2016 | 179 | 0.170 |
Why?
|
Amino Acids | 2 | 2023 | 252 | 0.170 |
Why?
|
Virus Shedding | 1 | 2018 | 26 | 0.170 |
Why?
|
Coccidiosis | 1 | 2018 | 2 | 0.170 |
Why?
|
Histocompatibility Antigens Class II | 4 | 2018 | 158 | 0.170 |
Why?
|
Mammalian orthoreovirus 3 | 1 | 2018 | 1 | 0.160 |
Why?
|
Interferon-alpha | 2 | 2018 | 233 | 0.160 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2018 | 79 | 0.160 |
Why?
|
Liver | 2 | 2022 | 1230 | 0.160 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2018 | 40 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 41 | 0.160 |
Why?
|
Ileum | 1 | 2018 | 159 | 0.160 |
Why?
|
Micronutrients | 1 | 2017 | 17 | 0.160 |
Why?
|
Membrane Glycoproteins | 1 | 2000 | 428 | 0.160 |
Why?
|
CD3 Complex | 4 | 2017 | 135 | 0.150 |
Why?
|
Molecular Mimicry | 1 | 2017 | 20 | 0.150 |
Why?
|
Middle Aged | 16 | 2019 | 25028 | 0.150 |
Why?
|
Endocytosis | 1 | 2018 | 177 | 0.150 |
Why?
|
Feces | 4 | 2023 | 319 | 0.150 |
Why?
|
Immunohistochemistry | 3 | 2013 | 1753 | 0.150 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2009 | 213 | 0.150 |
Why?
|
Plasma Cells | 1 | 2017 | 80 | 0.150 |
Why?
|
Adolescent | 9 | 2018 | 8981 | 0.150 |
Why?
|
Budesonide | 1 | 2017 | 45 | 0.150 |
Why?
|
Metagenomics | 3 | 2023 | 83 | 0.150 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2017 | 143 | 0.150 |
Why?
|
Wnt-5a Protein | 1 | 2016 | 8 | 0.150 |
Why?
|
Pouchitis | 1 | 2017 | 44 | 0.140 |
Why?
|
Symbiosis | 4 | 2023 | 118 | 0.140 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 266 | 0.140 |
Why?
|
Antioxidants | 1 | 2017 | 223 | 0.140 |
Why?
|
Child | 8 | 2018 | 6927 | 0.140 |
Why?
|
Colonic Pouches | 1 | 2017 | 67 | 0.140 |
Why?
|
Sulfoglycosphingolipids | 2 | 2013 | 7 | 0.140 |
Why?
|
Biological Evolution | 2 | 2021 | 919 | 0.140 |
Why?
|
Oligopeptides | 1 | 2017 | 179 | 0.140 |
Why?
|
Proctocolectomy, Restorative | 1 | 2017 | 87 | 0.140 |
Why?
|
Bifidobacterium | 1 | 2015 | 16 | 0.140 |
Why?
|
Leukemia | 1 | 2018 | 320 | 0.140 |
Why?
|
Receptors, Leukotriene | 1 | 2015 | 10 | 0.140 |
Why?
|
Amyloidosis | 1 | 2017 | 115 | 0.140 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2015 | 22 | 0.140 |
Why?
|
Glucocorticoids | 2 | 2017 | 352 | 0.140 |
Why?
|
Child, Preschool | 5 | 2018 | 3612 | 0.130 |
Why?
|
Interleukin-6 | 2 | 2018 | 256 | 0.130 |
Why?
|
Viral Proteins | 1 | 2017 | 300 | 0.130 |
Why?
|
Duodenum | 4 | 2019 | 100 | 0.130 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 746 | 0.130 |
Why?
|
Isotretinoin | 1 | 2014 | 23 | 0.130 |
Why?
|
Immunity, Humoral | 1 | 2015 | 67 | 0.130 |
Why?
|
Lymph Nodes | 1 | 2018 | 533 | 0.130 |
Why?
|
Young Adult | 6 | 2019 | 5976 | 0.130 |
Why?
|
Mitochondria | 1 | 2018 | 535 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 645 | 0.120 |
Why?
|
Bacterial Proteins | 2 | 2019 | 864 | 0.120 |
Why?
|
Cytostatic Agents | 1 | 2013 | 4 | 0.120 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 93 | 0.120 |
Why?
|
Genome-Wide Association Study | 2 | 2018 | 1621 | 0.120 |
Why?
|
Apoptosis | 2 | 2018 | 1683 | 0.120 |
Why?
|
Dermatologic Agents | 1 | 2014 | 71 | 0.120 |
Why?
|
B7-H1 Antigen | 1 | 2015 | 250 | 0.120 |
Why?
|
Binding Sites | 2 | 2014 | 1098 | 0.120 |
Why?
|
Candidiasis | 1 | 2013 | 36 | 0.120 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 416 | 0.120 |
Why?
|
Antibodies | 1 | 2015 | 350 | 0.120 |
Why?
|
Alzheimer Disease | 1 | 2017 | 470 | 0.120 |
Why?
|
Jejunum | 3 | 2010 | 79 | 0.120 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 268 | 0.120 |
Why?
|
Stress, Physiological | 1 | 2015 | 227 | 0.110 |
Why?
|
Coculture Techniques | 2 | 2011 | 164 | 0.110 |
Why?
|
Aged | 11 | 2020 | 18415 | 0.110 |
Why?
|
Perforin | 1 | 2013 | 55 | 0.110 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 1376 | 0.110 |
Why?
|
Biopsy | 4 | 2019 | 1163 | 0.110 |
Why?
|
Taurocholic Acid | 1 | 2012 | 6 | 0.110 |
Why?
|
Bilophila | 1 | 2012 | 3 | 0.110 |
Why?
|
Clone Cells | 2 | 2023 | 213 | 0.110 |
Why?
|
Endoplasmic Reticulum | 1 | 2014 | 250 | 0.110 |
Why?
|
DNA | 3 | 2023 | 1294 | 0.110 |
Why?
|
Blotting, Western | 1 | 2014 | 782 | 0.110 |
Why?
|
Hybridomas | 2 | 2010 | 74 | 0.110 |
Why?
|
Transcriptome | 1 | 2017 | 580 | 0.110 |
Why?
|
Green Fluorescent Proteins | 1 | 2013 | 305 | 0.110 |
Why?
|
Stromal Cells | 1 | 2013 | 143 | 0.110 |
Why?
|
Lipids | 1 | 2013 | 269 | 0.110 |
Why?
|
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2011 | 4 | 0.100 |
Why?
|
Spleen | 1 | 2013 | 430 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 2357 | 0.100 |
Why?
|
Mice, Inbred NOD | 3 | 2019 | 187 | 0.100 |
Why?
|
Transfection | 1 | 2013 | 896 | 0.100 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 547 | 0.100 |
Why?
|
Dietary Fats | 1 | 2012 | 135 | 0.100 |
Why?
|
Gene-Environment Interaction | 1 | 2012 | 103 | 0.100 |
Why?
|
Hypersensitivity | 1 | 2013 | 154 | 0.100 |
Why?
|
Models, Biological | 3 | 2018 | 1749 | 0.100 |
Why?
|
Phylogeny | 2 | 2014 | 1137 | 0.100 |
Why?
|
Melanoma | 1 | 2015 | 459 | 0.100 |
Why?
|
Polyethylene Glycols | 1 | 2013 | 363 | 0.100 |
Why?
|
Polysaccharides, Bacterial | 1 | 2011 | 31 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 24 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 325 | 0.100 |
Why?
|
Bacteroides fragilis | 1 | 2011 | 42 | 0.100 |
Why?
|
Skin Neoplasms | 1 | 2015 | 546 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2018 | 1801 | 0.090 |
Why?
|
RNA, Long Noncoding | 1 | 2011 | 102 | 0.090 |
Why?
|
Base Sequence | 2 | 2006 | 2330 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 301 | 0.090 |
Why?
|
Neoplasms, Experimental | 1 | 2012 | 269 | 0.090 |
Why?
|
Toll-Like Receptor 4 | 1 | 2010 | 88 | 0.090 |
Why?
|
Gastrointestinal Tract | 2 | 2023 | 191 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 166 | 0.090 |
Why?
|
Hematopoietic Stem Cells | 2 | 2023 | 292 | 0.090 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 397 | 0.090 |
Why?
|
Biomarkers | 2 | 2017 | 1718 | 0.090 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 2426 | 0.090 |
Why?
|
Cell Degranulation | 1 | 2009 | 14 | 0.090 |
Why?
|
Survival Analysis | 2 | 2013 | 1538 | 0.090 |
Why?
|
Models, Molecular | 1 | 2013 | 1286 | 0.090 |
Why?
|
Enzyme Activation | 2 | 2009 | 692 | 0.090 |
Why?
|
Arachidonic Acid | 1 | 2009 | 63 | 0.090 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2010 | 190 | 0.090 |
Why?
|
Primary Cell Culture | 2 | 2019 | 72 | 0.090 |
Why?
|
Complementarity Determining Regions | 1 | 2008 | 24 | 0.080 |
Why?
|
Colony Count, Microbial | 1 | 2008 | 46 | 0.080 |
Why?
|
Cross Reactions | 1 | 2008 | 106 | 0.080 |
Why?
|
Static Electricity | 1 | 2008 | 89 | 0.080 |
Why?
|
Lactobacillus | 2 | 2019 | 21 | 0.080 |
Why?
|
Amides | 1 | 2008 | 60 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 113 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 115 | 0.080 |
Why?
|
STAT Transcription Factors | 1 | 2008 | 18 | 0.080 |
Why?
|
Crystallography, X-Ray | 3 | 2017 | 485 | 0.080 |
Why?
|
Mucous Membrane | 1 | 2008 | 83 | 0.080 |
Why?
|
Atrophy | 3 | 2022 | 117 | 0.080 |
Why?
|
Organic Cation Transport Proteins | 1 | 2007 | 13 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 1384 | 0.080 |
Why?
|
Quorum Sensing | 1 | 2007 | 26 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2006 | 1014 | 0.080 |
Why?
|
Lymphoma | 2 | 2006 | 262 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 879 | 0.070 |
Why?
|
Mutation | 2 | 2017 | 3968 | 0.070 |
Why?
|
Bacillus subtilis | 1 | 2007 | 89 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 1565 | 0.070 |
Why?
|
Plague Vaccine | 1 | 2006 | 14 | 0.070 |
Why?
|
Down-Regulation | 1 | 2008 | 504 | 0.070 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2006 | 18 | 0.070 |
Why?
|
Colonoscopy | 2 | 2019 | 264 | 0.070 |
Why?
|
Tissue Distribution | 1 | 2006 | 290 | 0.070 |
Why?
|
Bacterial Vaccines | 1 | 2005 | 41 | 0.070 |
Why?
|
Molecular Chaperones | 2 | 2016 | 111 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2006 | 144 | 0.070 |
Why?
|
Cell Lineage | 2 | 2018 | 273 | 0.070 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2005 | 53 | 0.070 |
Why?
|
Transcription, Genetic | 2 | 2020 | 1135 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 2 | 2019 | 194 | 0.060 |
Why?
|
Time Factors | 2 | 2012 | 5210 | 0.060 |
Why?
|
B-Lymphocytes | 3 | 2017 | 724 | 0.060 |
Why?
|
Enterocytes | 2 | 2018 | 18 | 0.060 |
Why?
|
Phenotype | 4 | 2018 | 2378 | 0.060 |
Why?
|
Cohort Studies | 3 | 2019 | 2767 | 0.060 |
Why?
|
CD8 Antigens | 3 | 2017 | 82 | 0.060 |
Why?
|
In Vitro Techniques | 1 | 2006 | 989 | 0.060 |
Why?
|
Cell Membrane | 1 | 2007 | 666 | 0.060 |
Why?
|
Caco-2 Cells | 2 | 2018 | 123 | 0.060 |
Why?
|
Neutrophils | 1 | 2005 | 307 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2019 | 1823 | 0.060 |
Why?
|
Specific Pathogen-Free Organisms | 2 | 2015 | 74 | 0.060 |
Why?
|
Risk Factors | 4 | 2018 | 5417 | 0.060 |
Why?
|
Peptides | 2 | 2023 | 639 | 0.060 |
Why?
|
Actinobacillus | 1 | 2023 | 3 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2019 | 1981 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2023 | 3640 | 0.060 |
Why?
|
Receptor Activity-Modifying Protein 1 | 1 | 2022 | 2 | 0.060 |
Why?
|
Phagocytosis | 1 | 2023 | 85 | 0.060 |
Why?
|
Mucus | 1 | 2022 | 19 | 0.060 |
Why?
|
Nociceptors | 1 | 2022 | 29 | 0.060 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2022 | 38 | 0.050 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2002 | 8 | 0.050 |
Why?
|
Secale | 1 | 2022 | 1 | 0.050 |
Why?
|
Hordeum | 1 | 2022 | 10 | 0.050 |
Why?
|
Immunosuppressive Agents | 2 | 2017 | 977 | 0.050 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2002 | 39 | 0.050 |
Why?
|
Interleukin-17 | 1 | 2023 | 101 | 0.050 |
Why?
|
Triticum | 1 | 2022 | 32 | 0.050 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2001 | 44 | 0.050 |
Why?
|
Molecular Weight | 1 | 2022 | 332 | 0.050 |
Why?
|
Chromatography, Liquid | 1 | 2022 | 104 | 0.050 |
Why?
|
Mammals | 1 | 2023 | 227 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2022 | 188 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 1169 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2022 | 293 | 0.050 |
Why?
|
Precancerous Conditions | 1 | 2002 | 196 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2001 | 152 | 0.050 |
Why?
|
Butyric Acid | 1 | 2020 | 11 | 0.050 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2020 | 13 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 376 | 0.050 |
Why?
|
Lymphoma, T-Cell | 1 | 2000 | 48 | 0.050 |
Why?
|
Cell Separation | 2 | 2010 | 196 | 0.050 |
Why?
|
Receptors, Interleukin-15 | 1 | 2019 | 8 | 0.050 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 85 | 0.040 |
Why?
|
Infant | 2 | 2011 | 3046 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 80 | 0.040 |
Why?
|
Placebo Effect | 1 | 2019 | 31 | 0.040 |
Why?
|
Cellular Reprogramming | 1 | 2019 | 37 | 0.040 |
Why?
|
Gene Targeting | 1 | 1999 | 72 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2019 | 86 | 0.040 |
Why?
|
Edetic Acid | 1 | 2018 | 43 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 231 | 0.040 |
Why?
|
Enzyme Precursors | 1 | 1998 | 20 | 0.040 |
Why?
|
Myxovirus Resistance Proteins | 1 | 2018 | 7 | 0.040 |
Why?
|
Netherlands | 1 | 2018 | 19 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2019 | 249 | 0.040 |
Why?
|
Eimeria | 1 | 2018 | 1 | 0.040 |
Why?
|
Collagenases | 1 | 2018 | 39 | 0.040 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2018 | 2 | 0.040 |
Why?
|
Paneth Cells | 1 | 2018 | 9 | 0.040 |
Why?
|
Toll-Like Receptor 7 | 1 | 2018 | 8 | 0.040 |
Why?
|
Cardiolipins | 1 | 2018 | 17 | 0.040 |
Why?
|
France | 1 | 2018 | 47 | 0.040 |
Why?
|
Mitochondrial Membranes | 1 | 2018 | 14 | 0.040 |
Why?
|
Immunologic Surveillance | 1 | 2018 | 14 | 0.040 |
Why?
|
Microfilament Proteins | 1 | 2020 | 208 | 0.040 |
Why?
|
Sequence Analysis, DNA | 1 | 2022 | 853 | 0.040 |
Why?
|
Receptors, IgG | 1 | 1998 | 52 | 0.040 |
Why?
|
Penetrance | 1 | 2018 | 44 | 0.040 |
Why?
|
Guanosine | 1 | 2018 | 29 | 0.040 |
Why?
|
Gene Deletion | 1 | 1999 | 329 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 134 | 0.040 |
Why?
|
Immunomodulation | 1 | 2018 | 55 | 0.040 |
Why?
|
Permeability | 1 | 2018 | 137 | 0.040 |
Why?
|
Gene Expression | 1 | 2002 | 1284 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2018 | 143 | 0.040 |
Why?
|
Neuroimmunomodulation | 1 | 2017 | 11 | 0.040 |
Why?
|
Lysosomes | 1 | 1998 | 104 | 0.040 |
Why?
|
Peyer's Patches | 1 | 2017 | 18 | 0.040 |
Why?
|
Treatment Failure | 1 | 2018 | 285 | 0.040 |
Why?
|
Selenium | 1 | 2017 | 44 | 0.040 |
Why?
|
Leukocyte Immunoglobulin-like Receptor B1 | 1 | 2017 | 2 | 0.040 |
Why?
|
Vomiting | 1 | 2019 | 193 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 2017 | 19 | 0.040 |
Why?
|
Histocytochemistry | 1 | 2017 | 130 | 0.040 |
Why?
|
Reoviridae | 1 | 2017 | 6 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 229 | 0.040 |
Why?
|
New Zealand | 1 | 2017 | 22 | 0.040 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2017 | 20 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2017 | 56 | 0.040 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2017 | 20 | 0.040 |
Why?
|
Cricetinae | 1 | 2018 | 560 | 0.040 |
Why?
|
Capsules | 1 | 2017 | 38 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 72 | 0.040 |
Why?
|
Genes, T-Cell Receptor | 1 | 2017 | 10 | 0.040 |
Why?
|
Vitamins | 1 | 2017 | 81 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2017 | 8489 | 0.040 |
Why?
|
CD4 Antigens | 1 | 2017 | 83 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2017 | 148 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 217 | 0.040 |
Why?
|
Retreatment | 1 | 2017 | 107 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1998 | 302 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2017 | 154 | 0.040 |
Why?
|
Tacrolimus | 1 | 1998 | 373 | 0.040 |
Why?
|
Genetic Engineering | 1 | 2017 | 114 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 937 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2017 | 6509 | 0.040 |
Why?
|
Odds Ratio | 1 | 2018 | 678 | 0.040 |
Why?
|
Body Weight | 1 | 2017 | 459 | 0.040 |
Why?
|
Prospective Studies | 3 | 2017 | 4213 | 0.040 |
Why?
|
Interferon Type I | 1 | 2017 | 175 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 231 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2017 | 399 | 0.030 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 3 | 2000 | 14 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 1998 | 996 | 0.030 |
Why?
|
Cell Survival | 1 | 2018 | 969 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2016 | 193 | 0.030 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 146 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2018 | 999 | 0.030 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2015 | 33 | 0.030 |
Why?
|
Biodiversity | 1 | 2017 | 197 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 916 | 0.030 |
Why?
|
Vancomycin | 1 | 2015 | 72 | 0.030 |
Why?
|
Italy | 1 | 2015 | 106 | 0.030 |
Why?
|
Sweden | 1 | 2014 | 40 | 0.030 |
Why?
|
NF-kappa B | 1 | 2018 | 444 | 0.030 |
Why?
|
Quality of Life | 1 | 2023 | 1585 | 0.030 |
Why?
|
Clonal Deletion | 1 | 2014 | 23 | 0.030 |
Why?
|
Cell Movement | 1 | 2018 | 758 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2015 | 113 | 0.030 |
Why?
|
Genotype | 1 | 2019 | 1851 | 0.030 |
Why?
|
Protein Conformation | 1 | 2017 | 881 | 0.030 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2014 | 95 | 0.030 |
Why?
|
Endoscopy | 1 | 2017 | 332 | 0.030 |
Why?
|
Candida albicans | 1 | 2013 | 32 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2013 | 77 | 0.030 |
Why?
|
Disease Progression | 1 | 2018 | 1531 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2013 | 99 | 0.030 |
Why?
|
Acinetobacter baumannii | 1 | 2013 | 26 | 0.030 |
Why?
|
Major Histocompatibility Complex | 1 | 2013 | 81 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2006 | 1047 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2013 | 44 | 0.030 |
Why?
|
Enterococcus faecalis | 1 | 2013 | 46 | 0.030 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2014 | 159 | 0.030 |
Why?
|
Phosphates | 1 | 2013 | 160 | 0.030 |
Why?
|
Risk | 1 | 2014 | 674 | 0.030 |
Why?
|
Immunophenotyping | 2 | 2007 | 211 | 0.030 |
Why?
|
Virulence | 1 | 2013 | 271 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 532 | 0.030 |
Why?
|
Safflower Oil | 1 | 2012 | 7 | 0.030 |
Why?
|
Taurine | 1 | 2012 | 11 | 0.030 |
Why?
|
Sulfites | 1 | 2012 | 26 | 0.030 |
Why?
|
Genes, MHC Class I | 1 | 2012 | 48 | 0.030 |
Why?
|
Diet, Fat-Restricted | 1 | 2012 | 30 | 0.030 |
Why?
|
Milk | 1 | 2012 | 53 | 0.030 |
Why?
|
Pyrroles | 1 | 2013 | 184 | 0.030 |
Why?
|
Inclusion Bodies | 1 | 2012 | 34 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 2012 | 61 | 0.030 |
Why?
|
Piperidines | 1 | 2013 | 181 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2011 | 48 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 2011 | 154 | 0.020 |
Why?
|
Registries | 1 | 2014 | 702 | 0.020 |
Why?
|
Logistic Models | 1 | 2014 | 1186 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2010 | 147 | 0.020 |
Why?
|
Cecum | 1 | 2010 | 68 | 0.020 |
Why?
|
Pyrimidines | 1 | 2013 | 370 | 0.020 |
Why?
|
Caspases | 1 | 2010 | 155 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2010 | 97 | 0.020 |
Why?
|
Immunoblotting | 1 | 2010 | 268 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2010 | 96 | 0.020 |
Why?
|
Dimerization | 1 | 2010 | 143 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 2012 | 262 | 0.020 |
Why?
|
Pregnancy | 1 | 2017 | 2894 | 0.020 |
Why?
|
Liver Transplantation | 1 | 1998 | 1268 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2010 | 369 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2011 | 294 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2018 | 7993 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2010 | 123 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 1621 | 0.020 |
Why?
|
Thymus Gland | 1 | 2010 | 195 | 0.020 |
Why?
|
Genetic Variation | 1 | 2015 | 1351 | 0.020 |
Why?
|
Oxazoles | 1 | 2008 | 19 | 0.020 |
Why?
|
Granzymes | 1 | 2008 | 93 | 0.020 |
Why?
|
Catalysis | 1 | 2008 | 203 | 0.020 |
Why?
|
Alleles | 1 | 2011 | 1128 | 0.020 |
Why?
|
Solute Carrier Family 22 Member 5 | 1 | 2007 | 5 | 0.020 |
Why?
|
Lactoglobulins | 1 | 2007 | 8 | 0.020 |
Why?
|
Spores, Bacterial | 1 | 2007 | 18 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2008 | 87 | 0.020 |
Why?
|
Kinetics | 1 | 2010 | 1513 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2007 | 135 | 0.020 |
Why?
|
Brain | 1 | 2017 | 2216 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2000 | 927 | 0.020 |
Why?
|
Genome, Human | 1 | 2011 | 756 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2006 | 95 | 0.020 |
Why?
|
Transformation, Bacterial | 1 | 2005 | 5 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2005 | 21 | 0.020 |
Why?
|
Fluorescence | 1 | 2005 | 102 | 0.020 |
Why?
|
Paris | 1 | 2004 | 5 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 639 | 0.020 |
Why?
|
Microvilli | 1 | 2004 | 43 | 0.020 |
Why?
|
New York City | 1 | 2004 | 59 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2005 | 351 | 0.020 |
Why?
|
Vaccination | 1 | 2006 | 254 | 0.020 |
Why?
|
Immune System | 1 | 2005 | 93 | 0.020 |
Why?
|
Homozygote | 1 | 2004 | 200 | 0.020 |
Why?
|
HeLa Cells | 1 | 2005 | 498 | 0.020 |
Why?
|
Mitosis | 1 | 2004 | 153 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 425 | 0.010 |
Why?
|
New York | 1 | 2003 | 69 | 0.010 |
Why?
|
Diarrhea | 1 | 2004 | 182 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 557 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 736 | 0.010 |
Why?
|
Age Distribution | 1 | 2003 | 204 | 0.010 |
Why?
|
United States | 1 | 2015 | 6672 | 0.010 |
Why?
|
Diet, Protein-Restricted | 1 | 2000 | 3 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2000 | 303 | 0.010 |
Why?
|
Comorbidity | 1 | 2003 | 943 | 0.010 |
Why?
|
Epithelium | 1 | 2000 | 319 | 0.010 |
Why?
|
Incidence | 1 | 2003 | 1577 | 0.010 |
Why?
|
Syk Kinase | 1 | 1998 | 6 | 0.010 |
Why?
|
Endosomes | 1 | 1998 | 75 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2000 | 427 | 0.010 |
Why?
|
Biological Transport | 1 | 1998 | 396 | 0.010 |
Why?
|
Communicable Diseases | 1 | 1998 | 63 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1998 | 379 | 0.010 |
Why?
|
Survival Rate | 1 | 2000 | 1863 | 0.010 |
Why?
|
Risk Assessment | 1 | 2003 | 2261 | 0.010 |
Why?
|
Prognosis | 1 | 2000 | 3679 | 0.010 |
Why?
|
Rats | 1 | 1998 | 3990 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1998 | 2207 | 0.000 |
Why?
|